Thinking Systematically About the Off-Label Use of Cancer Drugs and Combinations for Patients Who Have Exhausted Proven Therapies

  • Mailankody S
  • Prasad V
5Citations
Citations of this article
40Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

This article explores the circumstances under which providers and patients should be able to attempt drugs or combinations for indications for which we still lack formal clinical trials.

Cite

CITATION STYLE

APA

Mailankody, S., & Prasad, V. (2016). Thinking Systematically About the Off-Label Use of Cancer Drugs and Combinations for Patients Who Have Exhausted Proven Therapies. The Oncologist, 21(9), 1031–1032. https://doi.org/10.1634/theoncologist.2016-0086

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free